All News
STAT+: At hearing, Makary nods to MAHA’s goals but says little about basic FDA policies
Trump's FDA nominee promises transparency and a focus on chronic disease, but is less forthright on medication abortion and advisory committees.
Read MoreAre President Trump's Executive Orders on Health Legal?
(MedPage Today) -- Since taking office, President Trump has signed a barrage of executive orders taking aim at major programs, agencies, and institutions, ranging from healthcare and public health to
Read MoreNuts and IBD Risk; AI Screening for Liver Disease; Norovirus Vax Shows Early Promise
(MedPage Today) -- Nut and legume consumption was not associated with a higher risk of inflammatory bowel disease (IBD), but people with overweight or obesity had a lower risk of Crohn's disease with
Read MoreRFK Jr.’s muting of public comment in HHS rules draws pushback
A coalition of nearly two dozen patient advocacy groups urges RFK Jr. to retain HHS's commitment to public participation in rule making.
Read MoreTwo Docs Accused of Sexual Abuse; Arizona Hospital Shooting; Nurse Accused of Murder
(MedPage Today) -- Two Tennessee physicians are facing sexual abuse allegations.
Read MoreA dispatch from HIMSS, and Trump’s chilling effect on health AI
In this edition of STAT Health Tech: A dispatch from HIMSS 2025, and Trump's chilling effect on health AI research.
Read MoreEZH2 Inhibitor Cuts Risk of Progression in Metastatic Prostate Cancer
(MedPage Today) -- A randomized phase II trial presented at this year's American Society of Clinical Oncology Genitourinary Cancers Symposium found that adding the EZH2 inhibitor mevrometostat to enz
Read MoreFederal Judge Blocks Drastic NIH Funding Cuts to Medical Research
(MedPage Today) -- A federal judge on Wednesday blocked the Trump administration from drastically cutting medical research funding that many scientists say will endanger patients and cost jobs.
Read MoreAmgen starts late-stage studies of MariTide
And more biotech news stories from The Readout.
Read MoreSTAT+: We’re reading about an FDA quality lab lease, Marty Makary’s confirmation hearing, and more
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab
Read More